PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance

Background: Acquired resistance of chemotherapy, especially cisplatin, is a major challenge in lung cancer treatment. We conducted this study to examine whether a cyclin D kinase 4/6 (CDK4/6) inhibitor, PD 0332991, could reverse cisplatin resistance in human lung cancer cells. In addition, we explor...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Thorac Cancer
Main Authors: Liu, Minghui, Cui, Liyuan, Li, Xin, Xia, Chunqiu, Li, Yongwen, Wang, Rui, Ren, Fan, Liu, Hongyu, Chen, Jun
Formáid: Artigo
Teanga:Inglês
Foilsithe: John Wiley & Sons Australia, Ltd 2021
Ábhair:
Original Articles
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7952807/
https://ncbi.nlm.nih.gov/pubmed/33534964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13866
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla